Patient Guide: A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 25 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05039515
Status: ACTIVE_NOT_RECRUITING
Condition: Fibrodysplasia Ossificans Progressiva
Phase: PHASE2

Find a Study Location Near You

This study is available at 25 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • San Francisco, California
  • Rochester, Minnesota
  • Philadelphia, Pennsylvania
  • • And 22 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily